Topokine Therapeutics, Inc.

Quick facts

Phase 2 pipeline

• TAT4 Gel
• XOPH5 Ointment

Phase 1 pipeline

• TAT4 Gel concentration A
• TAT4 Gel concentration B
• XAF5, concentration A
• XAF5, concentration B
• XAF5, concentration C

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Topokine Therapeutics, Inc. portfolio CI brief
• Topokine Therapeutics, Inc. pipeline updates RSS